Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 236 (abbreviated RNA5SP236 or RN5S236) is classified as a rRNA pseudogene in the human genome[2][4][5][8]. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional; they arise from gene duplication or retrotransposition events and typically lack protein-coding or functional RNA activity due to sequence mutations or regulatory deficiencies[6][8]. Unlike the functional 5S ribosomal RNA, which participates in ribosome assembly and protein synthesis, RNA5SP236 does not have a known biological function and is not expressed as a normal component of ribosomes[1][3][11]. No drugs, disease roles, or safety considerations are currently associated with this entity. Its designation as a pseudogene means it does not serve as a therapeutic target and should not be confused with functional ribosomal RNA genes[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 236 (RNA5SP236).